Rznomics Inc. South Korea Indiana

Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics

Co-development of precision RNA therapeutics for inherited hearing loss treatmentView original content to download multimedia:https://www.prnewswire.co.uk/news-releases/rznomics-enters-global-licensing-agreement-with-eli-lilly-for-rna-editing-therapeutics-302456854.html